Our Latest Posts
Did You Know?
Our Latest Facebook Posts
A great article about the relationship between Stress & Migraine~
It is our Question of the Week...as we are not all early birds! We want to hear from you~
Question of the Week from Migraine Canada!
Emgality (galcanezumab) is an injectable CGRP antibody. It targets CGRP itself. Aimovig (erenumab) targets the CGRP receptor so they are different. Emgality has also been tested for cluster headache and is expected to be available in Canada for this indication if the Health Canada review...